Research Project
Research Project
批准号:
10708974
负责人:
John C Lieske
金额:
$35.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-23 至 2025-06-30
关键词:
AffectAge MonthsAgingAnimal ModelAnimalsAnti-Inflammatory AgentsApplications GrantsAreaBiological MarkersBiopsyBloodCalciumCalcium OxalateCell secretionCellsClinicalCrystal FormationCrystallizationDataDefectDepositionDevelopmentDiseaseDuct (organ) structureEffectivenessEpithelial CellsEventExcretory functionExperimental Animal ModelFrequenciesFutureGrantGrowthHumanHydroxyapatitesHyperoxaluriaIn VitroIndividualInflammatoryKidneyKnock-outKnockout MiceLiquid substanceMacrophageMapsMentorshipMetabolic DiseasesMorbidity - disease rateMusOperative Surgical ProceduresPainPapillaryPathogenesisPathogenicityPatientsPersonsPhagocytesPhagocytosisPhenotypePlayPopulationPreventionProcessRecurrenceRenal TissueRenal tubule structureResearch PersonnelResearch Project GrantsRiskRisk FactorsRoleSaltsSamplingScientistSignaling MoleculeSpatial DistributionSurfaceSurgeonTestingTissuesTubular formationUrinary CalculiUrineUrologic DiseasesVirulence FactorsWild Type MouseWomanWorkbiobankbrushitecalcificationcalcium phosphatechemokinecomparison controlcostcytokinedesignexosomeexperienceextracellular vesicleshuman tissuehypercalciuriainflammatory markerinnovationinterstitialmenmicrovesiclesmonocytemouse modelmultidisciplinarynew therapeutic targetnon-invasive monitornovelpotential biomarkerprospectiverecruitresponseskillsurinary
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract:
Urinary stone disease (USD) is the 3rd most common urological disease in men and women. Prevention of
USD and its associated costs and morbidity requires an understanding of early and late USD pathogenesis.
Emerging evidence suggests pathophysiological interactions between intrarenal crystal nucleation, growth, and
phagocytic cellular responses may play a key but unrecognized role in USD. Studies in vitro demonstrate that
calcium phosphate (CaP) and calcium oxalate (CaOx) crystals induce renal tubular and phagocytic cellular
secretion of cytokines, chemokines, and extracellular vesicles (EVs; exosomes and microvesicles). These
biomarkers can attract blood or residential monocytes and convert monocytes into pro (M1) or anti (M2)-
inflammatory macrophages (Mφ ’s ). Observations in experimental animal models and human tissues suggest
that renal tissue monocytes and Mφ ’s can phagocytose and metabolize intrarenal crystals, and urinary stone
formers appear to have increased medullary M1 and decreased M2 Mφ populations. In a hyperoxaluric mouse
model, suppression of monocyte to M2 Mφ conversion significantly increased intrarenal CaOx deposition. Our
studies also demonstrated that urinary excretion of EVs bearing inflammatory markers derived from specific
segments of renal tubules were significantly lower in idiopathic calcium stone formers (ICSFs) compared to
controls. Thus, multiple lines of evidence suggest that tubular and monocyte derived Mφ populations can
phagocytose and degrade crystals as a crystal clearance mechanism, and defects in these clearance
mechanisms could promote interstitial Randall’s plaque (RP) and/or collecting duct plug (CDP) formation. The
proposed research project is designed to evaluate the role of Mφ ’s in RP and CDP formation using a novel
hypercalciuric claudin-2 global knockout mouse model (over 3-24 months age) that resembles the phenotype of
patients with idiopathic hypercalciuria and USD (Aim 1), and to define the frequency and spatial distribution of
monocyte/ Mφ populations in carefully phenotyped ICSFs (20-70 years) with hydroxyapatite, brushite, and
calcium oxalate stones plus varying amounts of RP (Aim 2). The proposed innovative study will elucidate the
role of renal medullary pro-and anti-inflammatory phagocytic cells in the development of RP, CDP, and USD
and whether urinary cytokines, chemokines or EVs carrying biomarkers of pro-/anti-inflammatory phagocytic
cells can be used to non-invasively monitor intrarenal crystal deposition. Completion of this study will also
facilitate the formation of a skilled multidisciplinary team including a promising early-stage surgeon-scientist (Dr
Kevin Koo) under the mentorship of an experienced and skilled USD clinical and researcher (Dr. Lieske). The
resulting preliminary data will provide evidence of the effectiveness of our team. This work will also enable
submission of future detailed grant or center proposals that will extend these mechanistic studies, and has
great potential to elucidate underlying pathogenic steps in USD genesisto identify novel therapeutic targets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Admin Core
-
批准号:10595344
-
项目类别:
-
资助金额:$3.98万
-
财政年份:2022
-
负责人:John C Lieske
-
依托单位:
Renal macrophages in the pathogenesis of human urinary stones and Randall's plaque formation in mice
-
批准号:10708970
-
项目类别:
-
资助金额:$39.41万
-
财政年份:2022
-
负责人:John C Lieske
-
依托单位:
Admin Core
-
批准号:10708971
-
项目类别:
-
资助金额:$3.98万
-
财政年份:2022
-
负责人:John C Lieske
-
依托单位:
Renal macrophages in the pathogenesis of human urinary stones and Randall's plaque formation in mice
-
批准号:10595343
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2022
-
负责人:John C Lieske
-
依托单位:
Research Project
-
批准号:10595345
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2022
-
负责人:John C Lieske
-
依托单位:
Improving stone disease treatment by accurate phenotyping and risk stratification
-
批准号:9135351
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2013
-
负责人:John C Lieske
-
依托单位:
Improving stone disease treatment by accurate phenotyping and risk stratification
-
批准号:8598968
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2013
-
负责人:John C Lieske
-
依托单位:
Improving stone disease treatment by accurate phenotyping and risk stratification
-
批准号:9343372
-
项目类别:
-
资助金额:$10.38万
-
财政年份:2013
-
负责人:John C Lieske
-
依托单位:
Genetic determinants of urine lithogenicity
-
批准号:7920691
-
项目类别:
-
资助金额:$10.08万
-
财政年份:2009
-
负责人:John C Lieske
-
依托单位:
Defining the natural history and treatment options for Dent Disease
-
批准号:7934954
-
项目类别:
-
资助金额:$22.58万
-
财政年份:2009
-
负责人:John C Lieske
-
依托单位:
Mayo Clinic Urology O'Brien Research Center
-
批准号:7984836
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2009
-
负责人:John C Lieske
-
依托单位:
Pilot and Feasibility Program
-
批准号:7934955
-
项目类别:
-
资助金额:$9.96万
-
财政年份:2009
-
负责人:John C Lieske
-
依托单位:
Mayo Clinic Urology O'Brien Research Center
-
批准号:7984844
-
项目类别:
-
资助金额:$6.42万
-
财政年份:2009
-
负责人:John C Lieske
-
依托单位:
Mayo Clinic Urology O'Brien Research Center
-
批准号:7924752
-
项目类别:
-
资助金额:$98.31万
-
财政年份:2008
-
负责人:John C Lieske
-
依托单位:
Mayo Clinic Urology O'Brien Research Center
-
批准号:7589347
-
项目类别:
-
资助金额:$98.31万
-
财政年份:2008
-
负责人:John C Lieske
-
依托单位:
Genetic determinants of urine lithogenicity
-
批准号:7570682
-
项目类别:
-
资助金额:$40.82万
-
财政年份:2008
-
负责人:John C Lieske
-
依托单位:
Mayo Clinic Urology O'Brien Research Center
-
批准号:8533495
-
项目类别:
-
资助金额:$5.18万
-
财政年份:2008
-
负责人:John C Lieske
-
依托单位:
Mayo Clinic Urology O'Brien Research Center
-
批准号:8328100
-
项目类别:
-
资助金额:$98.31万
-
财政年份:2008
-
负责人:John C Lieske
-
依托单位:
Mayo Clinic Urology O'Brien Research Center
-
批准号:8150214
-
项目类别:
-
资助金额:$2.88万
-
财政年份:2008
-
负责人:John C Lieske
-
依托单位:
Mayo Clinic Urology O'Brien Research Center
-
批准号:8132610
-
项目类别:
-
资助金额:$98.31万
-
财政年份:2008
-
负责人:John C Lieske
-
依托单位: